Peregrine Capital Management LLC Iovance Biotherapeutics, Inc. Transaction History

Peregrine Capital Management LLC

$3.18 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 26, 2023	BUY	$5.53 - $8.22 $49,233 - $73,182	8,903 Added 3.05%	301,068 $1.84 Million
Q4 2022 Jan 10, 2023	BUY	$5.62 - $10.0 $284,771 - $506,710	50,671 Added 20.98%	292,165 $1.87 Million
Q3 2022 Oct 26, 2022	SELL	$9.53 - $13.11 $126,920 - $174,598	-13,318 Reduced 5.23%	241,494 $2.31 Million
Q2 2022 Jul 20, 2022	SELL	$6.38 - $18.33 $18,910 - $54,330	-2,964 Reduced 1.15%	254,812 $2.81 Million
Q1 2022 Apr 27, 2022	BUY	$12.38 - $19.1 $73,363 - $113,186	5,926 Added 2.35%	257,776 $4.29 Million
Q4 2021 Jan 31, 2022	BUY	$16.55 - $27.63 $761,564 - $1.27 Million	46,016 Added 22.36%	251,850 $4.81 Million
Q3 2021 Nov 02, 2021	SELL	$20.35 - $26.63 $829,221 - $1.09 Million	-40,748 Reduced 16.53%	205,834 $5.08 Million
Q2 2021 Aug 03, 2021	BUY	$16.33 - $33.07 $169,799 - $343,861	10,398 Added 4.4%	246,582 $6.42 Million
Q1 2021 May 11, 2021	SELL	$28.67 - $52.59 $947,400 - $1.74 Million	-33,045 Reduced 12.27%	236,184 $7.48 Million
Q4 2020 Jan 19, 2021	SELL	$28.04 - $50.26 $2.86 Million - $5.12 Million	-101,839 Reduced 27.44%	269,229 $12.5 Million
Q3 2020 Oct 20, 2020	SELL	$27.75 - $36.3 $980,490 - $1.28 Million	-35,333 Reduced 8.69%	371,068 $12.2 Million
Q2 2020 Jul 30, 2020	BUY	$27.21 - $41.0 $734,207 - $1.11 Million	26,983 Added 7.11%	406,401 $11.2 Million
Q1 2020 Apr 17, 2020	SELL	$19.54 - $38.85 $3.18 Million - $6.32 Million	-162,558 Reduced 29.99%	379,418 $11.4 Million
Q4 2019 Jan 16, 2020	SELL	$17.95 - $29.41 $1.82 Million - $2.98 Million	-101,439 Reduced 15.77%	541,976 $15 Million
Q3 2019 Oct 16, 2019	SELL	$17.99 - $26.0 $256,105 - $370,136	-14,236 Reduced 2.16%	643,415 $11.7 Million
Q2 2019 Jul 18, 2019	SELL	$9.78 - $24.52 $1.7 Million - $4.26 Million	-173,864 Reduced 20.91%	657,651 $0
Q1 2019 Apr 12, 2019	BUY	$8.41 - $11.26 $6.99 Million - $9.36 Million	831,515 New	831,515 $0

Others Institutions Holding IOVA

# of Institutions

320

Shares Held

239M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $977M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peregrine Capital Management LLC with notifications on news.

Account